Stryker (SYK) is in advanced talks to acquire Inari Medical (NARI), which makes devices that treat patients with venous diseases, people familiar with the matter told Reuters’ Anirban Sen. A deal could be announced as soon as this week if the talks are successful, the sources said. Such a deal for Inari, which has a market value of almost $3B, would strengthen Stryker’s efforts to expand its offerings to treat a blood-vein clotting condition known as venous thromboembolism, the author notes. Inari shares are up over 20% after the news.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Inari in talks to be acquired by Stryker, Reuters reports
- Stryker near deal to buy Inari Medical, Reuters reports
- Stryker price target raised to $400 from $384 at Evercore ISI
- Stryker price target raised to $409 from $380 at Truist
- Stryker added to ‘Conviction List’, price target raised to $442 at Needham